These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 21868824)
21. Advances in antiretroviral therapy. Olender S; Wilkin TJ; Taylor BS; Hammer SM Top Antivir Med; 2012; 20(2):61-86. PubMed ID: 22710908 [TBL] [Abstract][Full Text] [Related]
22. Antiretroviral therapy and resistance to antiretroviral drugs. Lange JM; van Leeuwen R Ethiop Med J; 2002 Apr; 40 Suppl 1():51-75. PubMed ID: 12802831 [TBL] [Abstract][Full Text] [Related]
23. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years? Mehta M; Semitala F; Lynen L; Colebunders R Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1287-96. PubMed ID: 23241186 [TBL] [Abstract][Full Text] [Related]
24. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization. Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694 [TBL] [Abstract][Full Text] [Related]
25. Treatment interruption in HIV therapy: a SMART strategy? Jülg B; Goebel FD Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667 [TBL] [Abstract][Full Text] [Related]
26. [Antiretroviral therapy for HIV infection]. Lozano F; Domingo P Enferm Infecc Microbiol Clin; 2011; 29(6):455-65. PubMed ID: 21489658 [TBL] [Abstract][Full Text] [Related]
27. [AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)]. ; Enferm Infecc Microbiol Clin; 2010; 28(6):362.e1-91. PubMed ID: 20554079 [TBL] [Abstract][Full Text] [Related]
29. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)]. Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725 [TBL] [Abstract][Full Text] [Related]
30. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Lima V; Fernandes K; Rachlis B; Druyts E; Montaner J; Hogg R Soc Sci Med; 2009 Mar; 68(6):1044-9. PubMed ID: 19157668 [TBL] [Abstract][Full Text] [Related]
31. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense. Kitkungvan D; Apisarnthanarak A; Laowansiri P; Mundy LM HIV Med; 2008 Oct; 9(8):636-41. PubMed ID: 18643857 [TBL] [Abstract][Full Text] [Related]
32. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Resino S; Resino R; Maria Bellón J; Micheloud D; Gutiérrez MD; de José MI; Ramos JT; Fontelos PM; Ciria L; Muñoz-Fernández MA; Clin Infect Dis; 2006 Jul; 43(2):243-52. PubMed ID: 16779753 [TBL] [Abstract][Full Text] [Related]
34. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression. Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Holloway J; Johnson M; Phillips AN HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781 [TBL] [Abstract][Full Text] [Related]
35. [Advances in antiretroviral therapy]. Antunes F Acta Med Port; 2012; 25(3):193-6. PubMed ID: 23069240 [TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780 [TBL] [Abstract][Full Text] [Related]
37. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
38. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Tadios Y; Davey G Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389 [TBL] [Abstract][Full Text] [Related]
39. What's new in the fight against AIDS. Godwin C RN; 2004 Apr; 67(4):46-52; quiz 53. PubMed ID: 15132046 [No Abstract] [Full Text] [Related]
40. Advances in antiretroviral therapy. Sobieszczyk ME; Jones J; Wilkin T; Hammer SM Top HIV Med; 2006; 14(1):36-62. PubMed ID: 16641526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]